NCT03263988

Brief Summary

Measurement of arterial blood pressure is a basic monitoring in the perioperative setting. It is a standard monitoring to assure an adequate cerebral perfusion pressure and is a basic parameter of hemodynamic optimization. Until now standard methods for blood pressure measurement are non-invasive interval monitoring by arm cuff (Riva-Rocci) or direct, continuous and invasive by inserting an intraarterial catheter. This observational study will show, that a new non-invasive piezocapacitative-interlayer technology will make continuous blood pressure monitoring and non-invasive pulse contour analysis available.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 21, 2017

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 28, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

October 19, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2018

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

August 21, 2017

Last Update Submit

February 13, 2025

Conditions

Keywords

pulse contour analysiscaptonintraoperative monitoring

Outcome Measures

Primary Outcomes (1)

  • PPV

    Percentual error of PPV \< 30% for ConCardiac between ConCardiac and PICCO

    Duration of surgery and perioperative care (an average of 24 hours)

Secondary Outcomes (26)

  • Duration of surgery

    Duration of surgery (an average of 4 hours)

  • Duration of anesthesia

    Duration of surgery (an average of 4 hours)

  • intraoperative blood loss

    Duration of surgery and perioperative care (an average of 24 hours)

  • Duration of mechanical ventilation

    Duration of surgery (an average of 4 hours)

  • Duration of renal replacement therapy

    perioperative (an average of 10 days)

  • +21 more secondary outcomes

Study Arms (1)

PIEZO-Group

All patients in this study receive IBP by PICCO and piezocapacitative-interlayer-technology measurement.

Device: ConCardiac

Interventions

All patients receive a piezocapacitative-interlayer-technology hemodynamic measurement by ConCardiac device (SectorCon GmbH, Berlin, Germany).

PIEZO-Group

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

18 years or older voluntary patients undergoing elective surgery at Charité - Universitätsmedizin Berlin Campus Charite Mitte

You may qualify if:

  • elective surgery and general anesthesia
  • age \>/= 18 years
  • any surgery in ENT/trauma/gynecology/visceral surgery/thoracic surgery/urology/neuro surgery/cardio surgery (N=10)
  • cardio surgery (N=10)
  • Transcatheter Aortic Valve Implantation (N=20)
  • cystectomy (N=10)
  • neurosurgery with an expected postoperative ICU stay \>/= 20 hours (N=10)

You may not qualify if:

  • pregnant or breastfeeding patients
  • emergency surgery
  • participation in a clinical interventional study
  • BMI \>35 kg/m²
  • impossibility to place the ConCardiac interlayer
  • difference of blood pressure of right and left arm \> 12 mmHg
  • pAVK Fontaine IV
  • arrythmia absoluta
  • vitium cordis \>/=3
  • ejection fraction \<35%
  • TAPSE \</=16mm
  • need of IABP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité - Universitätsmedizin Berlin Campus Charité Mitte

Berlin, State of Berlin, 10115, Germany

Location

Related Publications (6)

  • Giglio MT, Marucci M, Testini M, Brienza N. Goal-directed haemodynamic therapy and gastrointestinal complications in major surgery: a meta-analysis of randomized controlled trials. Br J Anaesth. 2009 Nov;103(5):637-46. doi: 10.1093/bja/aep279.

    PMID: 19837807BACKGROUND
  • Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care. 2002 Jun;6(3):199-204. doi: 10.1186/cc1489. Epub 2002 Apr 18.

    PMID: 12133178BACKGROUND
  • Scheeren TW, Wiesenack C, Gerlach H, Marx G. Goal-directed intraoperative fluid therapy guided by stroke volume and its variation in high-risk surgical patients: a prospective randomized multicentre study. J Clin Monit Comput. 2013 Jun;27(3):225-33. doi: 10.1007/s10877-013-9461-6. Epub 2013 Apr 5.

    PMID: 23558909BACKGROUND
  • Auler JO Jr, Galas F, Hajjar L, Santos L, Carvalho T, Michard F. Online monitoring of pulse pressure variation to guide fluid therapy after cardiac surgery. Anesth Analg. 2008 Apr;106(4):1201-6, table of contents. doi: 10.1213/01.ane.0000287664.03547.c6.

    PMID: 18349193BACKGROUND
  • Dalfino L, Giglio MT, Puntillo F, Marucci M, Brienza N. Haemodynamic goal-directed therapy and postoperative infections: earlier is better. A systematic review and meta-analysis. Crit Care. 2011 Jun 24;15(3):R154. doi: 10.1186/cc10284.

    PMID: 21702945BACKGROUND
  • Sun Y, Lacour SP, Brooks RA, Rushton N, Fawcett J, Cameron RE. Assessment of the biocompatibility of photosensitive polyimide for implantable medical device use. J Biomed Mater Res A. 2009 Sep 1;90(3):648-55. doi: 10.1002/jbm.a.32125.

    PMID: 18563817BACKGROUND

Study Officials

  • Sascha Treskatsch, MD

    Charite University, Berlin, Germany

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med./ Deputy head of department

Study Record Dates

First Submitted

August 21, 2017

First Posted

August 28, 2017

Study Start

October 19, 2017

Primary Completion

October 23, 2018

Study Completion

December 31, 2019

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations